Incannex
Incannex moves to the NASDAQ
Incannex Healthcare Inc. (NASDAQ: IXHL) has redomiciled Incannex Healthcare from Australia to the United States, November 28, 2023 New York time (November 29, 2023 Melbourne time).
Incannex
Incannex Healthcare Inc. (NASDAQ: IXHL) has redomiciled Incannex Healthcare from Australia to the United States, November 28, 2023 New York time (November 29, 2023 Melbourne time).
IHL-216A
IHL-216A is a combination drug that combines CBD with any volatile anaesthetic agent, including isoflurane. IHL-216A has been designed to be administered soon after head trauma to reduce secondary brain injuries that lead to neurological deficits.